In this retrospective study, we developed and validated a reinforcement learning (RL)-based deep learning (DL) model that can non-invasively identify the SOX9 status of hepatocellular carcinoma (HCC) patients preoperatively, providing support for personalized treatment. This evidence concerns the gene SOX9 and hepatocellular carcinoma.